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Abstract 
Previous research has indicated that purified perivascular stem cells (PSCs) have 
increased chondrogenic potential compared to conventional mesenchymal stem cells 
(MSCs) derived in culture. This study aimed to develop an autologous large animal 
model for perivascular stem cell transplantation, and to specifically determine if 
implanted cells are retained in articular cartilage defects. 
Immunohistochemistry and fluorescence-activated cell sorting (FACS) were used to 
ascertain the reactivity of anti-human and anti-ovine antibodies, which were 
combined and used to identify and isolate pericytes (CD34-CD45-CD146+) and 
adventitial cells (CD34+CD45-CD146-). The purified cells demonstrated osteogenic, 
adipogenic and chondrogenic potential in culture. 
Autologous ovine PSCs (oPSCs) were isolated, cultured and efficiently transfected 
using a GFP encoding lentivirus. The cells were implanted into articular cartilage 
defects on the medial femoral condyle using a hydrogel and collagen membranes. 
Four weeks following implantation the condyle was explanted and confocal laser 
scanning microscopy demonstrated the presence of oPSCs in the defect repaired with 
the hydrogel.  
These data suggest the testability in a large animal of native mesenchymal stem cell 
autologous grafting, thus avoiding possible biases associated with xenotransplantation. 
Such a setting will be used in priority for indications in orthopaedics, at first to model 
articular cartilage repair. 
 
  
Introduction 
Perivascular stem cells (PSCs) have been identified as the natural ancestors of 
mesenchymal stem cells (MSCs), and are the in vivo cells responsible for tissue 
homeostasis and repair[1,2]. They have demonstrated increased osteogenic potential 
compared to unpurified cells[3] and our research has indicated increased 
chondrogenic potential compared to culture-derived MSCs[4]. They have also 
demonstrated the ability to form skeletal muscle[5], lung[6] and myocardium[1]. 
Perivascular stem cells can be isolated suing specific cell surface markers. In previous 
research pericytes have been isolated based on their expression of CD146[1,7]. 
Pericytes have also been shown to express PDGFRβ[8,9]. Adventitial cells are 
isolated based on their expression of CD34. Neither express either endothelial or 
haematopoietic markers. 
To ascertain how well particular cells perform in vivo prior to human clinical trials, 
the use of animal models is required[10-12]. These models allow the efficacy and 
safety of the proposed methods to be tested in a biological and mechanical 
environment similar to those that would be encountered in clinical practice.  
The International Cartilage Repair Society recommends that whilst small animal 
models are useful for initial studies and proof of concept work, large animal studies 
are required for pivotal studies[12]. A canine model of perivascular stem cells has 
previously been developed and used at the University of California in Los Angeles (R 
Hardy, X Zhang, P Liang, J Kwak, E Ting, C Soo, B Péault, unpublished). The use of 
canines in animal research in the United Kingdom is socially unacceptable and 
unlikely to be approved by the Home Office due to their status as companion animals.  
Sheep have successfully been used for implantation of autologous chondrocytes on a 
collagen matrix[13] and for chondrocytes and MSCs embedded in gels[10-12,14-16]. 
Godoy et al (2014) used sheep to compare stem cells from bone marrow, adipose 
tissue and synovium[17]. Their research indicated that MSCs could be harvested from 
each of these sources and that MSCs from each source shared the ability to from bone, 
cartilage and fat as well as sharing a similar immunophenotype based on expression 
of the marker CD44. These data demonstrated the feasibility of obtaining ovine stem 
cells. 
Whilst pericytes have been identified in the ovine corpus luteum, their perivascular 
location has not been confirmed in multiple organs as they have in human 
tissues[18,19]. There have been no reports identifying the role of adventitial cells as a 
source of stem cells in the ovine model. Neither cell type has been identified using 
cell surface antigens in a similar manner to human tissue nor have they been isolated 
using antibody labeling and fluorescence-activated cell sorting (FACS). Without 
using similar methods used for human PSCs it is harder to state that the ovine PSCs 
are truly analogous and therefore an equivalent model. 
The ovine stifle joint has been described as a surgical model to represent the human 
knee joint[20]. The anatomy of the ovine stifle joint has been well described and is 
considered a reasonable model of the human knee joint[20,21]. It has been used to 
investigate articular cartilage repair as well as anterior cruciate ligament (ACL) 
reconstruction[22] and meniscal repair[23] and replacement[24].  
Caplan et al (2011) proposed the idea that MSCs work using a paracrine effect, 
essentially acting as a ‘drug store’ to aid in tissue regeneration[25]. It is implied that 
the basis of cell-based repairs must be the cells that are introduced into the defects. 
There are very few studies that have labeled and tracked the cells that have been 
placed into articular cartilage defects, raising the question of the fate of the implanted 
cells. Proposed cell tracking methods include PKH26[26], iron oxide 
nanoparticles[27], DiI and transfection using green fluorescence protein (GFP)[28]. 
Nakamura et al (2012) used GFP emission to ascertain that injected cells stayed in 
place following insertion, their DiI labeled cells remained in the defect at 7 days but 
were not seen at 1 or 3 months[28]. Miot et al (2010) implanted GFP labeled human 
chondrocytes into goats on a Chondro-Gide membrane and found the cells in the 
defect after four weeks[29]. 
The primary aim of this research was to develop a large animal model of autologous 
perivascular stem cells that could be used to translate laboratory based research to 
human clinical trials. The secondary aim was to test the model for articular cartilage 
repair and to determine if cells were engrafted by surgical implantation. 
Materials and methods 
Ethical approvals 
All animal research was conducted in accordance with the Animals (Scientific 
Procedures) Act 1986 under Protocol 15 of project licence PPL 60/4052. All of the 
experimental protocols were reviewed by the University of Edinburgh’s Named 
Veterinary Surgeons. 
Tissue harvest and cell isolation 
Cadaveric tissue was obtained for use for the identification, isolation and 
characterization of ovine PSCs prior to conducting the animal surgeries. Cadaveric 
tissue was harvested within 1hr of sacrifice and transported to the laboratory in 
transport media (Dulbeccos’ Modified Eagle Medium (DMEM) / 10% Fetal Bovine 
Serum (FBS) / 1% Penicillin-Streptomycin (PS)). 
Tissue samples were mechanically disrupted to ensure they were less than 1mm3 and 
were covered with digestion medium (DMEM / 10% FBS, 1% PS and 0.5% 
collagenases I, II and IV). The tissue was digested in a shaking water bath (37°C	,	150	rpm)	 for	 50min.	 The	 digested	 suspension	 was	 centrifuged	 at	 1,800rpm	 for	10min	 .	 The	 pellets	 were	 re-suspended	 in	 25ml	 2%	 FBS	 /	 PBS	 (5mM	
ethylenediaminetetraacetic acid (EDTA)).	The	tissue	suspensions	were	successively	filtered	through	a	200μm	nylon	mesh	and	then	100,	70	and	40μm	cell	strainers.	The	 strained	 suspensions	 were	 centrifuged	 at	 1,500rpm	 for	 10min.	 The	supernatant	was	 aspirated	 and	 discarded	 and	 the	 pellets	 re-suspended	 in	 1ml	20%	FBS	/	DMEM	/	1%	PS.	
Histology and immunohistochemistry 
Tissue samples were resected so that they were less than 2cm3 to ensure rapid and 
complete fixation in 4% formalin. Fixed tissue was placed in Tissue-Tek® cassettes 
(Sakura Finetek) and processed using a Leica ASP processor using sequential alcohol, 
xylene and paraffin wax steps.  Tissue was subsequently embedded into molten wax, 
allowed to solidify on a cold plate and sectioned 7µm thick. Sections were incubated 
at 55°C over night, de-waxed(xylene 5min three times) and rehydrated(100% ethanol 
2min three times, 95, 80 and 50% ethanol 2min each and then washed under running 
water). Slides were stained as per the sections below and then dehydrated (50, 80 and 
95% ethanol for 30s each and 100% ethanol for 2min three times) and mounted using 
xylene.  
Sections were incubated in Harris haematoxylin(Sigma-Aldrich) for 5min and then 
washed under running water. They were differentiated in 1% hydrochloric acid in 
ethanol and transferred to a dish of Scott’s tap water substitute for 2min until the 
tissue sections turned blue. Slides were counter-stained in eosin for 2min and were 
washed briefly under running water. 
Slides were brought to room temperature (RT) and fresh frozen sections fixed in an 
ice-cold bath of methanol and acetone (50:50) for 10min. Slides were air dried for 
5min at RT prior to being washed (each washing step consisted of three 5min washes 
at 50rpm on a rotating platform, once with Phosphate Buffered Saline (PBS) / Tween 
(0.5mL/L Tween 20 pH 7.4) and twice with PBS alone). Slides were incubated with 
protein block (DAKO) for 1hr at RT and then washed. Slides were incubated with 
avidin D for 15min followed by a PBS wash followed by incubation with biotin for 
15min followed by a further PBS wash. Sections were incubated with the primary 
antibody in antibody diluent (DAKO) overnight at 4°C. The following day sections 
were washed and incubated with a biotinylated secondary antibody against the host 
species of the primary antibody diluted 1:1000 in antibody diluent (DAKO) for 1hr at 
RT. Sections were incubated with streptavidin-AF488 or streptavidin–AF555 
(Invitrogen) diluted 1:1000 in antibody diluent for 1h at RT. The sections were 
washed for a final time and mounted with a single drop of 4',6-diamidino-2-
phenylindole (DAPI) mounting medium and then cover slipped. Stained sections were 
stored at 4°C in the dark until imaged. 
For multiple stains, primary antibodies raised in different species were used where 
possible. The primary and secondary antibodies were incubated at the same time (i.e. 
primary mouse anti-human and rabbit anti-human with secondary goat anti-mouse 
and goat anti-rabbit).  
Histochemical staining was imaged using a bright-field setting and colour camera 
with a Zeiss Observer Microscope. An Olympus BX61 fluorescence microscope was 
used to sequentially record the emission from the individual fluorophores used for 
immunohistochemistry, these were subsequently merged to form a composite image. 
Controls using isotypes were imaged under identical conditions. 
Fluorescence-activated cell sorting 
The cells were blocked in 10% mouse serum in PBS and left at RT for 20 min, 100µl 
for analysis and 500µl for cell sorting. Antibodies were added to the cell suspension 
in the dark at a dilution of 1:100 unless otherwise stated. All antibodies were tested 
using the stromal vascular fraction (SVF) from multiple tissues; all samples were 
compared to their corresponding isotype except the anti-VWF-FITC, which used an 
unstained sample as its negative control.  
The cells were incubated for 20min on ice in the dark. The cells were washed in 2ml 
of PBS and centrifuged at 1,000rpm for 5min. The supernatant was aspirated and 
discarded and the pellet re-suspended in 2% FBS/PBS, 300µl for analysis and 500µl 
for cell sorts. 
For each antibody a compensation tube was set up using a single drop of positive 
compensation beads(BD Biosciences) diluted with 70µl 2% FBS/PBS and stained in 
an identical manner to the cells. These were re-suspended in a final volume of 270µl 
and a drop of negative control beads added just prior to FACS analysis or sorting. 
Gates were set using negative controls to determine the level of true-positive staining. 
Cell Culture 
FACS sorted cells were collected in 300µl endothelial cell growth medium(EGM-2, 
Lonza) as pericytes(CD34-CD45-CD146+) and adventitial cells(CD34+CD45-
CD146-). Wells and flasks were pre-coated with 0.2%(w/v) gelatin(Calbiochem) for 
10 min at 4°C. Cells were plated at a density of approximately 4x104/cm2 in EGM-2 
and cultured at 37°C, 5% CO2. The EGM-2 medium was changed after 7 days and 
then every 4 days after that until the cells reached 90-100% confluency. From passage 
1(P1) onwards all cells were cultured in DMEM / 20% FBS / 1% PS. Cells were 
washed twice in PBS and then incubated in 0.05% trypsin-EDTA at 37°C, 5% CO2 
for 3 to 5min until >90% of the cells were mobilised. Complete medium was added to 
the plate / flask and the cell suspension transferred to a 15ml centrifuge tube. The 
cells were pelleted by centrifuging at 1,000rpm for 5min. The supernatant was 
aspirated and discarded and the pellet re-suspended for further culture expansion, 
differentiation or flow cytometry. Freshly isolated SVF was used for identifying the 
reactivity of FACS antibodies, the cell characterization and differentiation was 
undertaken with passage 6 cells. 
Immunocytochemistry 
For immunocytochemistry the PBS was removed and the cells permeabilised with 
0.05% Triton-PBS for 3min at room RT. The cells were washed three times with PBS 
and then blocked with Protein Block(Dako) for 1h at RT. Cells were washed in PBS 
and then incubated with the primary antibody overnight at 4°C. The following 
morning the wells were washed three times for 5min, once with PBS-Tween and 
twice w 
ith PBS. Cells were incubated with the secondary antibody for 1h at RT in the dark. 
After a further three washes the cover slips were removed and any excess fluid 
removed. The cover slips were mounted onto slides using DAPI fluoromount and 
allowed to air dry for 1hr in the dark before being fixed in place with an adhesive. 
Mesenchymal differentiation and functional histochemical staining 
Monolayer differentiation was undertaken using ten wells of a 24-well plate, five 
wells were used for growth medium(DMEM / 10% FBS / 1% PS) and five for 
differentiation medium(HyClone AdvanceSTEM osteogenic and adipogenic media, 
GE Life Sciences). The cells were diluted to a concentration of 2x104/ml and 1ml 
added to each well. Plates were incubated at 37oC, 5% CO2 until they were 50-70% 
confluent at which point they were considered to be at day 0 of the differentiation 
course. Plates were taken at day 0 as controls. The medium was removed from those 
plates undergoing differentiation and replaced with 1ml of either growth(DMEM / 
10% FBS / 1% PS) or differentiation medium. The media were changed twice weekly 
for 21 days. 
Three-dimensional pellet culture was used for chondrogenic differentiation. After cell 
counting, the cells were re-suspended in either chondrogenic medium(HyClone 
AdvanceSTEM, GE Life Sciences) or DMEM / 10% FBS / 1% PS at a concentration 
of 6x105 cells/ml and 500µl pipetted into an individual well of a 96-well v-bottom 
plate. Cells were pelleted by centrifugation at 800rpm for 5min followed by 
incubation at 37°C, 5% CO2. Three pellets were used for growth medium controls and 
three for differentiation medium. The medium was changed twice weekly by 
centrifuging the plates at 800rpm for 5min, the medium was aspirated, discarded and 
replaced with fresh medium. After medium changes the pellets were gently agitated to 
ensure that they were not adherent. 
Osteogenic differentiation was determined by using Alizarin red to form a bi-
refringent complex with calcium deposits. Alizarin red solution was made by adding 
2g alizarin red S(C.I. 58005) to 100mL dH20. This was thoroughly mixed and the pH 
altered to 4.1-4.3 with 10% ammonium hydroxide. The wells were stained with 1ml 
Alizarin red solution for approximately 30min at RT to produce red-orange staining 
with calcium. Excess stain was removed by washing four times with dH20. 
Adipogenic differentiation was assessed using Oil Red O. A stock solution was 
prepared by mixing 0.7g Oil Red O(Sigma O-062) with 200ml isopropanol. This was 
stirred overnight and then passed through a 0.2µm filter. The stock solution was 
stored at 4oC. The working solution was made by adding six parts stock solution to 
four parts distilled water(dH20). This was mixed and left at RT for 20min before 
being passed through a 0.2µm filter. The wells were washed twice with dH20 and then 
dehydrated with 60% isopropanol for 5min at RT. The isopropanol was removed and 
the wells dried without washing. The cells were stained with 1ml Oil Red O solution 
for 10min at RT. Excess stain was removed by washing four times with dH2O. 
Chondrogenic differentiation was indicated by Alcian blue staining for proteoglycans. 
Slides or wells were incubated with acetic acid for 3min at RT followed by Alcian 
blue for 30min at RT. Excess stain was removed using acetic acid and the slides were 
washed three times with dH2O. 
Animal surgery 
Sheep were induced with propofol (5-6mg/kg) and maintained on 2-3% isoflurane 
(Abbot Laboratories Ltd.). Velergesic (Buprenorphine, Reckett Benckiser Healthcare 
Ltd.) was used for post-operative analgesia (14µg/kg) for 3-4 days. Streptacare 
(Procaine Penicillin, 20% Dihydrostreptomycin, Animalcare Ltd) was given as 
prophylactic antibiotics (1ml/25kg) for 5-7 days. 
The sheep were placed in the supine position, for unilateral surgery the contra-lateral 
limb was secured away from the surgical field. The wool was sheared and the skin 
prepared with a Betadine / alcohol solution. The hoof was placed in a sterile bag and 
the limb draped. 
The stifle joints were opened using a midline incision followed by a medial 
parapatellar arthrotomy. The infra-patellar fat pad (IFP) was excised with a scalpel 
and placed in DMEM / 10% FBS / 1% PS for transport to the laboratory. Thorough 
haemostasis was carried out using bipolar diathermy. The medial femoral condyle 
(MFC) was exposed by flexion of the stifle joint and a circular lesion made in the 
cartilage using a punch biopsy. The cartilage was then excised using a 4mm ring 
curette.  
The arthrotomy was closed with a continuous 1 Vicryl suture and the subcutaneous fat 
with a running 2/0 Vicryl suture. The skin was closed with deep dermal and sub-
cuticular 2/0 Vicryl sutures. The wound was cleaned with Betadine spray and left 
without a dressing. 
Lentivirus transfection 
An emerald Green Fluorescent Protein (eGFP) lentivirus under the control of a 
cytomegalovirus promoter was used. The virus was stored at -80°C and the final virus 
titre was calculated to be 4.35x106 infectious units/µl. Perivascular stem cells were 
transfected at approximately 80% confluence. The culture medium was aspirated and 
discarded and the cells washed twice in PBS. Serum-free medium (5ml) was mixed 
with 1µl virus for every 0.8-1.0x106 cells giving a multiplicity of infection of 
approximately five. The cells were incubated at 37°C for 4-5hrs. DMEM 
supplemented with 20% FBS / 1% PS (5ml) was added and the cells incubated over 
night. The following morning the cells were washed twice in PBS and the medium 
replaced. 
Cell loading 
The cell-loaded collagen membranes were prepared using two separate methods to 
duplicate techniques currently used in clinical practice. In both techniques cells were 
grown ex vivo, trypsinised, pelleted and re-suspended in 1ml DMEM for counting. 
The first method mimicked Genzyme’s method of delivering the cells for surgery pre-
seeded on the membrane. This was done by pipetting the cells onto the ChondroGide 
membrane at a density of 1x106 cells per cm2. The membranes were left to incubate in 
a 12-well plate for 4h prior to adding additional culture media. The cell membranes 
were left for 48-72h prior to re-insertion. During surgery the cartilage defect was 
debrided back to a stable rim and a template made to fill the defect. The membrane 
was then cut to shape and glued into place using Tisseel fibrin glue (Baxter).  
The second method was based on TiGenix’s ChondroCelect procedure. Cells were 
transported to surgery in 100µl phenol-free DMEM as this is used as the transport 
medium for Matrix-assisted chondrocyte implantation (MACI) membranes provided 
by Genzyme. The articular cartilage defect was debrided back to a stable rim, and the 
membrane cut to fit the defect. Cells were then pipetted onto the membrane at an 
approximate density of 1x106 cells per cm2. The membrane	was	then	placed	into	the	defect	and	the	edges	sealed	with	Tisseel	fibrin	glue.	
In	 situ	 crosslinking	 of	 cells	 encapsulated	 in	 a	 hydrogel	 was	 performed	 using	HyStem®-C	Hydrogel	Kit(Esi	Bio,	GS313)	as	per	the	manufacturer’s	instructions.	Approximately	 1x106	 cells	 were	 re-suspended	 in	 100μl	 inactivated	 hydrogel,	during	surgery	the	hydrogel	the	cross-linker	was	added.	Once	the	viscosity	was	high	 enough	 to	 allow	 the	 hydrogel	 to	 remain	 in	 the	 defect	 it	 was	 pipetted	 in	slowly	and	left	for	at	least	30min	to	cross-link	in	situ.	
Ex vivo cell tracking A	 Zeiss	 Axioskop	 510(Carl	 Zeiss	 Ltd,	Welwyn	Garden	 City,	 UK)	 Confocal	 Laser	Scanning	 Microscope	 (CLSM)	 was	 used	 to	 image	 cell	 cytoplasm	 (5-chloromethylfluorescein	diacetate	(CMFDA))	of	viable	cells	and	the	cell	nuclei	of	non-viable	cells	(Propidium	iodide	(PI))	on	MACI	membranes.	The	x10	objective	was	 used	 to	 obtain	 images	 for	 cell	 counting	 and	 the	 x63	 objective	 for	 higher	magnification	to	observe	cell	phenotype.	The	CMFDA	was	excited	using	an	Argon	laser	at	488nm	and	the	emission	detected	using	a	bandpass	filter	at	525/50nm.	Propidium	iodide	was	excited	using	a	helium-neon	laser	at	543nm	and	detected	with	a	long-pass	filter	at	>560nm.	An	average	of	two	readings	was	used	for	each	pixel	to	reduce	background	signal.	The	gain	and	amplifier	settings	were	adjusted	to	 allow	 the	maximal	 use	 of	 the	 detectable	 range.	 Axial	 images	were	 collected	throughout	 the	 entire	 fluorescently	 visible	 z-axis	 at	 intervals	 of	 5.7μm	 for	 the	x10	objective	and	0.75μm	for	the	x63	objective.		eGFP	transfected	cells	were	imaged	using	the	same	acquisition	protocol	used	for	CMFDA	 with	 excitation	 at	 488nm	 and	 a	 peak	 emission	 at	 507nm(525/50nm	bandpass	filter).	For	the	hydrogel	encapsulated	cells	optical	sections	were	taken	
at	5.7μm	throughout	the	z-axis.	The	implanted	cells	were	identified	using	the	x10	objective	 and	 imaged	 using	 optical	 slices	 every	 5.7μm.	 Higher	 magnification	images	acquired	optical	sections	0.75μm	apart.	
Results 
Histology and immunohistochemistry of multiple ovine tissues 
Histology of ovine adipose sections demonstrated the same microscopic structure as 
human tissue with the majority of the tissue being pale where the processing has 
removed the adipose tissue leaving a mesh of cell membranes interspersed with blood 
vessels of varying calibers, from capillaries to arterioles (Figure 1A). Sections from 
skeletal muscle had blood vessels running in between the myofibres (Figure 1B). A 
section taken through the synovial border of the infra-patellar fat pad demonstrated a 
large concentration of cells and blood vessels adjacent to the synovium with adipose 
tissue lying underneath(Figure 1C) with the same structure as subcutaneous fat(Figure 
1A). 
Anti-human CD146 antibodies positively identified small caliber blood vessels in 
multiple tissues. Sections from placenta and myocardium are shown in Figure 1D and 
E respectively. An anti-ovine CD34 antibody was confirmed to stain in a perivascular 
location(Figure 1F) and this was confirmed to share a perivascular location with 
CD146(Figures 1G and I). Isotype controls were used for all sections to determine the 
presence of any false-positive staining; the isotype control for the dual stains in 
Figures 1G and I is shown in Figure 1H. Multiple anti-human and anti-ovine CD31 
antibodies were used to try and identify an endothelial marker but no positive staining 
was seen compared to isotype controls (data not shown). 
Reactivity and cross-reactivity of antibodies to identify ovine perivascular stem cells 
Flow cytometry antibodies raised against human and ovine tissues were tested for 
their cross-reactivity and reactivity with freshly isolated ovine stromal vascular 
fraction (Table 1). The majority of the antibodies did not demonstrate a positive 
signal with ovine cells, including the anti-ovine anti-CD31 antibody(data not shown). 
Figure 2 shows the results for the anti-human CD146 antibody as well as the anti-
ovine CD34, CD45 and PDGFR-β (platelet-derived growth factor) antibodies. Whilst 
there was not a large peak when the staining with the anti-human CD146 antibody 
and isotype were overlaid (Figure 2A, left-hand plot) the density plots clearly 
identified a population of CD146+ cells when compared to the isotype control. 
Similar results were seen for the anti-CD34 and anti-PDGFR-β antibodies. Only the 
anti-CD45 antibody demonstrated a large peak when the histograms were overlaid. 
These data meant that ovine perivascular stem cells could be identified and 
haematopoietic stem cells excluded. 
Ovine SVF was stained with anti-human CD146 as well as anti-ovine CD34 and 
CD45 antibodies with DAPI used to exclude dead cells(Figure 3A). Full minus one 
controls were used to determine the level of true-staining (Figure 3A - bottom middle 
and right plots). Distinct cell populations were identified as pericytes (CD45-
CD146+CD34-) and adventitial cells (CD45-CD146-CD34+) in the bottom left plot in 
Figure 3A. Ovine pericytes and adventitial cells collected using FACS were re-
analysed immediately after the cell sort. The pericytes are shown in the upper plots in 
Figure 3B and demonstrate that 84% of the re-analysed events were the same cell size 
and 100% of these events were CD146+ indicating a pure cell sort. Over 90% of the 
adventitial cells were in the cell selection gate with 100% of these cells being CD34+. 
The events that were outside of the cell selection gate are likely to represent debris 
from non-viable cells. It was impossible to determine the true level of cell death as 
one cell would lead to multiple pieces of debris in an unpredictable manner. 
As the articular cartilage repair model was to use the infra-patellar fat pad the 
variability in the number of pericytes that could be obtained was investigated using 
the infra-patellar fat from four separate stifle joints (two animals). The FACS plots 
used to select the pericytes and adventitial cells are shown in Figure 3C. Whilst there 
was variability in the levels of staining, pericytes and adventitial cells were identified 
and isolated from each of the specimens. 
In vitro characterization of ovine perivascular stem cells including mesenchymal 
differentiation 
Ovine pericytes and adventitial cells in monolayer culture are shown in Figures 4A 
and B respectively. Pericytes from ovine bone marrow were analysed using FACS 
and were CD34-CD45-CD146+. The histogram in Figure 4C for the anti-human 
CD146 antibody demonstrated a large CD146+ population (red) with clear staining 
compared to the isotype control (blue). Cultured ovine pericytes from the infra-
patellar fat pad did not demonstrate CD146 staining on FACS but did with 
immunocytochemistry compared to controls (Figures D and E). 
Ovine pericytes and adventitial cells both demonstrated the ability of osteogenic, 
adipogenic and chondrogenic differentiation; the differentiation of ovine pericytes is 
shown in Figure 4. After 21 days in differentiation media the pericytes stained 
positively for alizarin red (calcium deposition with osteogenic medium, Figure 4G), 
Oil Red O (intracellular fat vacuoles, adipogenic medium, Figure 4I) and Alcian blue 
(proteoglycans with chondrogenic medium Figure 4J and L). Each of the stains was 
positive compared to cells from the growth medium controls (Figures 4F, H, I and K). 
Autologous ovine perivascular stem cells remain in situ following insertion using a 
hydrogel 
Ovine adventitial cells transfected with an emerald GFP virus demonstrated some 
positive signal on day 1 post transfection (Figure 5A), which appeared significantly 
increased by day 6 post transfection. An aliquot of the transfected cells was analysed 
using flow cytometry and demonstrated an 88% transfection rate compared to non-
transfected cells at day 6. 
Non-transfected cells were loaded onto a collagen I\III membrane and stained with 
CMFDA and PI. These cells were then imaged to determine that the loading protocol 
worked and that there were viable cells attached to the membrane prior to surgical 
implantation. Figures D and E show the cells attached to the membrane and 
demonstrate that almost all of the attached cells were viable. Transfected cells were 
successfully loaded into a hyaluronic acid based hydrogel at concentrations from 1-
20x104 cells/µl. Figure 5F is an extended focus view and demonstrates that the cells 
were not over-crowded. Figure 5G shows the GFP emitting virus in a single cell 
staining the cytoplasm clearly. 
Four weeks following surgical implantation the sheep were sacrificed and the stifle 
joints excised. The cartilage did not receive any fluorescent staining and confocal 
laser scanning microscopy was able to find GFP emitting cells in the base of the 
defect treated with the cell-loaded hydrogel (Figure 5H). A single cell with processes 
that did not look like a differentiated chondrocyte is shown at higher magnification in 
Figure 5I. No GFP emitting cells were found at the base of the defect treated with the 
cell-loaded collagen membranes. Cross sections of both defects stained with Masson’s 
trichrome did not demonstrate any repair tissue either with or without the traced 
perivascular stem cells.  
Discussion 
This work has successfully managed to identify and prospectively identify ovine 
perivascular stem cells using a similar set of perivascular markers to those used in 
humans[1,30].  
As there was a lack of anti-vine specific antibodies available to identify and isolate 
ovine PSCs the main challenge in developing an autologous model was the 
identification of antibodies to accurately select perivascular stem cells, this included 
determining if antibodies raised against another species (such as anti-human 
antibodies) would cross react appropriately with ovine cells. Immunohistochemistry 
demonstrated that anti-human CD146 antibodies cross-reacted with ovine tissue and 
that the antigens had a perivascular location (Figure 1D-I). The cross-reactivity of the 
CD146 antibody was validated further when the cultured pericytes from bone marrow 
were analysed with flow cytometry (Figure 3C) and immunocytochemistry (Figure 
3D-E). An ovine specific antibody was required to identify CD34 accurately[31]. 
Despite there being antibodies for ovine endothelial cell markers this research was 
unable to show that the anti-CD31 antibody worked. The anti-CD31 antibody was 
described by Pintado et al (1995)[32], who did not describe the use of any negative 
controls in their work; the fluorescence reported as representing a positive signal 
could therefore just represent increased voltage or auto-fluorescence. Zannettino et al 
(2010) used the same anti-ovine CD31 antibody in their paper comparing human and 
ovine MSCs[33]. All of their results were negative and no positive controls were used 
to demonstrate that the antibody worked. Their negative results could be true-
negatives but without positive controls it could just represent the lack of antibody 
reactivity. The	lack	of	an	endothelial	marker	in	the	antibody	panel	used	to	sort	oPSCs	meant	that	 endothelial	 cells	 would	 also	 have	 been	 collected.	 This	 was	 a	 particular	problem	 for	 adventitial	 cells:	 our	 previous	 data	 demonstrated	 that	 anti-CD34	antibodies	 stained	 a	 proportion	 of	 endothelial	 cells	 as	well	 (unpublished	 data,	Hindle	 et	 al). Despite	 PDGFRβ	 not	 being	 used	 commonly	 as	 a	marker	 to	 FACS	sort	human	PSCs,	this	research	suggests	that	it	could	be	a	useful	marker	for	the	
isolation	of	ovine	PSCs.	All	of	 the	CD146+	cells	 in	one	sort	were	PDGFRβ+.	The	ovine	antibody	was	able	to	identify	a	larger	number	of	ovine	PSCs	than	the	anti-human	CD146	antibody.	These	cells	would	need	to	be	isolated	and	compared	to	their	 human	 counterparts	 before	using	 them	 further.	 If	 the	 anti-ovine	PDGFRβ	antibody	were	 used	 it	would	mean	 that	 the	 entire	 antibody	 panel	would	 have	been	raised	specifically	to	react	with	ovine	cells. 
Ovine PSCs were isolated from bone marrow, subcutaneous fat and the infra-patellar 
fat pad. These data demonstrated that these were all feasible cell sources for future 
experiments. Ovine pericytes and adventitial cells demonstrated mesenchymal 
potential with osteogenic, chondrogenic and adipogenic differentiation. The cultured 
pericytes from bone marrow expressed CD146 and the ones from the infra-patellar fat 
pad did not, this was the same as the pericytes from the human IFPs[4].	In	 this	 manuscript	 we	 have	 concentrated	 on	 the	 use	 of	 CD146	 and	 CD34	 as	markers	to	identify	perivascular	stem	cells	as	this	 is	directly	comparable	to	the	methods	 used	 to	 isolate	 human	 PSCs	 that	 have	 demonstrated	 improved	osteogenic	 and	 chondrogenic	 potential	 compared	 to	 unsorted	 cells	 and	MSCs[3,4].	 CD146	has	 also	been	 indicated	as	 a	marker	 for	 a	 sub-population	of	chondroprogenitor	 cells	 in	 osteoarthritis[34]	 and	 CD146+	 cells	 have	demonstrated	 increased	 therapeutic	 potential	 compared	 to	 CD146-	 cells	 in	 a	model	 of	 murine	 arthritis[35].	 Other	 authors	 have	 investigated	 the	 use	 of	different	markers	including	Grem1+	and	LepR+	cells[36,37].	There	is	currently	a	lack	of	comparative	data	on	these	subsets	of	cell	populations. Finally,	 and	 importantly,	 our	 data	 demonstrated	 that	 the	 ovine	 model	 for	perivascular	 stem	 cells	 can	 be	 used	 for	 autologous	 articular	 cartilage	 repair.	Ovine	 pericytes	 and	 adventitial	 cells	 were	 isolated	 from	 the	 IFP;	 no	 problems	were	encountered	with	cell	isolation	or	proliferation. 
Insertion methods mimicking both of the commercially available MACI and 
ChondroCelect products were used. CLSM confirmed attachment in the MACI group 
with good cell viability (Figure 5D-E). No difference was noted with surgical 
preparation time or insertion. As the membrane was dry and stiff prior to applying the 
cells with the ChondroCelect method the membrane was easier to cut to shape. The 
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other insertion technique was using a hydrogel that cross linked in situ that had 
previously been described by Liu et al (2006) for osteochondral defects[38].  
Hydrogels based on hyaluronic acid and collagen I have been used in rabbits[38] and 
sheep[15] to deliver bone marrow derived MSCs. The hydrogel was easy to use and 
was able to insert a greater number of cells than the collagen membrane. The main 
challenge using the hydrogel was judging the viscosity so that the hydrogel remained 
in the defect when inserted but was not too viscous that it could not be inserted. The 
8mm circular defects used had a surface area of 50mm2, as the density of the cells on 
the collagen membrane was approximately 1x106 cells/cm2 this meant that 
approximately 5x105 cells would be inserted when the collagen membranes were used. 
The sheep’s cartilage was approximately 1mm thick to the calcified cartilage, giving a 
defect volume of 50mm3. The cells in the hydrogel were loaded at 20,000 cells/µl. 
This means about 1x106cells were inserted using the hydrogel. There was even 
potential to load more cells if research found this to be beneficial, this extra capacity 
was not demonstrated with the collagen membrane as the cells on a MACI membrane 
are in a monolayer and already occupy all of the available space[39]. 
Implanted cells were successfully tracked ex vivo using the GFP virus and CLSM. 
GFP emitting cells were identified at the base of the articular cartilage defect four 
weeks after insertion of the hydrogel (Figure 5H-I) despite no repair tissue being 
demonstrated on histology (Figure 5J). The high magnification image of the single 
GFP emitting cell did not have a rounded appearance of a chondrocyte. This might be 
due to stem cells acting more as trophic mediators[40] rather than engraftment and 
differentiation or just that four weeks is an early time point for seeing articular 
cartilage repair. 
In conclusion our data have demonstrated that there is now an autologous large 
animal model for furthering research into perivascular stem cells. The ovine model is 
more likely to be socially acceptable than the current canine model. Whilst we have 
demonstrated the models use in articular cartilage repair this model could be used for 
tissue engineering and regeneration across multiple organs. 
 
Acknowledgements: This work was made possible by grants from the University of 
Edinburgh and Tenovus Scotland 
Authors Disclosure Statement: None of the authors have any commercial 
associations that might create a conflict of interest. 
 
  
References 
1. Crisan M, S Yap, L Casteilla, C-W Chen, M Corselli, TS Park, G Andriolo, B Sun, 
B Zheng, L Zhang, C Norotte, P-N Teng, J Traas, R Schugar, BM Deasy, S Badylak, 
H-J Buhring, J-P Giacobino, L Lazzari, J Huard and B Péault (2008). A perivascular 
origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3: 301–
313. 
2. Zhao H, J Feng, K Seidel, S Shi, O Klein, P Sharpe and Y Chai (2014). Secretion 
of shh by a neurovascular bundle niche supports mesenchymal stem cell homeostasis 
in the adult mouse incisor. Cell Stem Cell 14: 160–173. 
3. James AW, JN Zara, X Zhang, A Askarinam, R Goyal, M Chiang, W Yuan, L 
Chang, M Corselli, J Shen, S Pang, D Stoker, B Wu, K Ting, B Peault and C Soo 
(2012). Perivascular Stem Cells: A Prospectively Purified Mesenchymal Stem Cell 
Population for Bone Tissue Engineering. Stem Cells Translational Medicine 1: 510–
519. 
4. Hindle P, N Khan, LC Biant and B Péault The infra-patellar fat pad as a source of 
perivascular stem cells with increased chondrogenic potential for regenerative 
medicine. In Press. Stem Cells Translational Medicine. 
5. Park TS, M Gavina, C-W Chen, B Sun, P-N Teng, J Huard, BM Deasy, L 
Zimmerlin and B Péault (2011). Placental perivascular cells for human muscle 
regeneration. Stem Cells Dev 20: 451–463. 
6. Montemurro T, G Andriolo, E Montelatici, G Weissmann, M Crisan, MR Colnaghi, 
P Rebulla, F Mosca, B Péault and L Lazzari (2011). Differentiation and migration 
properties of human foetal umbilical cord perivascular cells: potential for lung repair. 
J Cell Mol Med 15: 796–808. 
7. James AW, JN Zara, M Corselli, A Askarinam, AM Zhou, A Hourfar, A Nguyen, S 
Megerdichian, G Asatrian, S Pang, D Stoker, X Zhang, B Wu, K Ting, B Péault and C 
Soo (2012). An abundant perivascular source of stem cells for bone tissue engineering. 
Stem Cells Translational Medicine 1: 673–684. 
8. Gerhardt H and C Betsholtz (2003). Endothelial-pericyte interactions in 
angiogenesis. Cell Tissue Res 314: 15–23. 
9. Schwab KE and CE Gargett (2007). Co-expression of two perivascular cell markers 
isolates mesenchymal stem-like cells from human endometrium. Hum Reprod 22: 
2903–2911. 
10. Sah RL and A Ratcliffe (2010). Translational models for musculoskeletal tissue 
engineering and regenerative medicine. Tissue Eng Part B Rev 16: 1–3. 
11. Ahern BJ, J Parvizi, R Boston and TP Schaer (2009). Preclinical animal models in 
single site cartilage defect testing: a systematic review. Osteoarthr Cartil 17: 705–713. 
12. Hurtig MB, MD Buschmann, LA Fortier, CD Hoemann, EB Hunziker, JS Jurvelin, 
P Mainil-Varlet, CW McIlwraith, RL Sah and RA Whiteside (2011). Preclinical 
Studies for Cartilage Repair: Recommendations from the International Cartilage 
Repair Society. Cartilage 2: 137–152. 
13. Jones CW, C Willers, A Keogh, D Smolinski, D Fick, PJ Yates, TB Kirk and MH 
Zheng (2008). Matrix-induced autologous chondrocyte implantation in sheep: 
objective assessments including confocal arthroscopy. J Orthop Res 26: 292–303. 
14. Chu CR, M Szczodry and S Bruno (2010). Animal models for cartilage 
regeneration and repair. Tissue Eng Part B Rev 16: 105–115. 
15. Marquass B, R Schulz, P Hepp, M Zscharnack, T Aigner, S Schmidt, F Stein, R 
Richter, G Osterhoff, G Aust, C Josten and A Bader (2011). Matrix-associated 
implantation of predifferentiated mesenchymal stem cells versus articular 
chondrocytes: in vivo results of cartilage repair after 1 year. Am J Sports Med 39: 
1401–1412. 
16. Aigner T, JL Cook, N Gerwin, SS Glasson, S Laverty, CB Little, W McIlwraith 
and VB Kraus (2010). Histopathology atlas of animal model systems - overview of 
guiding principles. Osteoarthr Cartil 18 Suppl 3: S2–S6. 
17. Godoy RF, ALG Alves, AJ Gibson, EMM Lima and AE Goodship (2014). Do 
progenitor cells from different tissue have the same phenotype? Res Vet Sci 96: 454–
459. 
18. Redmer DA, V Doraiswamy, BJ Bortnem, K Fisher, A Jablonka-Shariff, AT 
Grazul-Bilska and LP Reynolds (2001). Evidence for a role of capillary pericytes in 
vascular growth of the developing ovine corpus luteum. Biol Reprod 65: 879–889. 
19. Beckman JD, AT Grazul-Bilska, ML Johnson, LP Reynolds and DA Redmer 
(2006). Isolation and characterization of ovine luteal pericytes and effects of nitric 
oxide on pericyte expression of angiogenic factors. Endocrine 29: 467–476. 
20. Allen MJ, JE Houlton, SB Adams and N Rushton (1998). The surgical anatomy of 
the stifle joint in sheep. Vet Surg 27: 596–605. 
21. Proffen BL, M McElfresh, BC Fleming and MM Murray (2012). A comparative 
anatomical study of the human knee and six animal species. Knee 19: 493–499. 
22. Heard BJ, NM Solbak, Y Achari, M Chung, DA Hart, NG Shrive and CB Frank 
(2013). Changes of early post-traumatic osteoarthritis in an ovine model of simulated 
ACL reconstruction are associated with transient acute post-injury synovial 
inflammation and tissue catabolism. Osteoarthr Cartil 21: 1942–1949. 
23. Koff MF, P Shah, S Pownder, B Romero, R Williams, S Gilbert, S Maher, LA 
Fortier, SA Rodeo and HG Potter (2013). Correlation of meniscal T2* with 
multiphoton microscopy, and change of articular cartilage T2 in an ovine model of 
meniscal repair. Osteoarthr Cartil 21: 1083–1091. 
24. Zur G, E Linder-Ganz, JJ Elsner, J Shani, O Brenner, G Agar, EB Hershman, SP 
Arnoczky, F Guilak and A Shterling (2011). Chondroprotective effects of a 
polycarbonate-urethane meniscal implant: histopathological results in a sheep model. 
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA 19: 
255–263. 
25. Caplan AI and D Correa (2011). The MSC: an injury drugstore. Cell Stem Cell 9: 
11–15. 
26. Ude CC, BS Shamsul, MH Ng, HC Chen, MY Norhamdan, BS Aminuddin and 
BHI Ruszymah (2012). Bone marrow and adipose stem cells can be tracked with 
PKH26 until post staining passage 6 in in vitro and in vivo. Tissue and Cell 44: 156–
163. 
27. Chen J, F Wang, Y Zhang, X Jin, L Zhang, Y Feng, X Lin and L Yang (2012). In 
vivo tracking of superparamagnetic iron oxide nanoparticle labeled chondrocytes in 
large animal model. Ann Biomed Eng 40: 2568–2578. 
28. Nakamura T, I Sekiya, T Muneta, D Hatsushika, M Horie, K Tsuji, T Kawarasaki, 
A Watanabe, S Hishikawa, Y Fujimoto, H Tanaka and E Kobayashi (2012). 
Arthroscopic, histological and MRI analyses of cartilage repair after a minimally 
invasive method of transplantation of allogeneic synovial mesenchymal stromal cells 
into cartilage defects in pigs. Cytotherapy 14: 327–338. 
29. Miot S, R Gianni-Barrera, K Pelttari, C Acharya, P Mainil-Varlet, H Juelke, C 
Jaquiery, C Candrian, A Barbero and I Martin (2010). In vitro and in vivo validation 
of human and goat chondrocyte labeling by green fluorescent protein lentivirus 
transduction. Tissue Eng Part C Methods 16: 11–21. 
30. Corselli M, M Crisan, IR Murray, CC West, J Scholes, F Codrea, N Khan and B 
Péault (2013). Identification of perivascular mesenchymal stromal/stem cells by flow 
cytometry. Cytometry A 83: 714–720. 
31. Porada CD, DD Harrison-Findik, C Sanada, V Valiente, D Thain, PJ Simmons, G 
Almeida-Porada and ED Zanjani (2008). Development and characterization of a novel 
CD34 monoclonal antibody that identifies sheep hematopoietic stem/progenitor cells. 
Experimental Hematology 36: 1739–1749. 
32. Pintado CO, J Perez de la Lastra and D Llanes (1995). A monoclonal antibody to 
an ovine gp130 molecule inhibits homotypic aggregation induced by anti-CD43 
monoclonal antibodies of ruminant leukocytes. Immunol Lett 45: 81–85. 
33. Zannettino ACW, S Paton, S Itescu and S Gronthos (2010). Comparative 
assessment of the osteoconductive properties of different biomaterials in vivo seeded 
with human or ovine mesenchymal stem/stromal cells. Tissue Eng Part A 16: 3579–
3587. 
34. Su X, W Zuo, Z Wu, J Chen, N Wu, P Ma, Z Xia, C Jiang, Z Ye, S Liu, J Liu, G 
Zhou, C Wan and G Qiu (2015). CD146 as a new marker for an increased 
chondroprogenitor cell sub-population in the later stages of osteoarthritis. J Orthop 
Res 33: 84–91. 
35. Wu C-C, F-L Liu, H-K Sytwu, C-Y Tsai and D-M Chang (2016). CD146(+) 
mesenchymal stem cells display greater therapeutic potential than CD146(-) cells for 
treating collagen-induced arthritis in mice. Stem Cell Res Ther 7: 23. 
36. Worthley DL, M Churchill, JT Compton, Y Tailor, M Rao, Y Si, D Levin, MG 
Schwartz, A Uygur, Y Hayakawa, S Gross, BW Renz, W Setlik, AN Martinez, X 
Chen, S Nizami, HG Lee, HP Kang, J-M Caldwell, S Asfaha, CB Westphalen, T 
Graham, G Jin, K Nagar, H Wang, MA Kheirbek, A Kolhe, J Carpenter, M Glaire, A 
Nair, S Renders, N Manieri, S Muthupalani, JG Fox, M Reichert, AS Giraud, RF 
Schwabe, J-P Pradere, K Walton, A Prakash, D Gumucio, AK Rustgi, TS 
Stappenbeck, RA Friedman, MD Gershon, P Sims, T Grikscheit, FY Lee, G Karsenty, 
S Mukherjee, et al. (2015). Gremlin 1 identifies a skeletal stem cell with bone, 
cartilage, and reticular stromal potential. Cell 160: 269–284. 
37. Chan CKF, EY Seo, JY Chen, D Lo, A McArdle, R Sinha, R Tevlin, J Seita, J 
Vincent-Tompkins, T Wearda, W-J Lu, K Senarath-Yapa, MT Chung, O Marecic, M 
Tran, KS Yan, R Upton, GG Walmsley, AS Lee, D Sahoo, CJ Kuo, IL Weissman and 
MT Longaker (2015). Identification and specification of the mouse skeletal stem cell. 
Cell 160: 285–298. 
38. Liu Y, XZ Shu and GD Prestwich (2006). Osteochondral defect repair with 
autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, 
cross-linked synthetic extracellular matrix. Tissue Eng 12: 3405–3416. 
39. Hindle P, AC Hall and LC Biant (2014). Viability of chondrocytes seeded onto a 
collagen I/III membrane for matrix-induced autologous chondrocyte implantation. J 
Orthop Res 32: 1495–1502. 
40. Caplan AI and JE Dennis (2006). Mesenchymal stem cells as trophic mediators. J 
Cell Biochem 98: 1076–1084. 
 
 
 
